133
This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Embed Size (px)

Citation preview

Page 1: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

This will be a session this morning covering

section 10Susan Vannoni

Dr Bogardus

Scott Simmons

Scott Simmons

THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 2: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

104

Radiation Radiation Clinical Clinical Treatment Treatment ManagementManagement

Covered by pages 1-49

Modified For 02-22-14

01031410:00 to 10:45 AM, Section #11

Section Section 1111

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 3: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

TOTAL CARE OF THETOTAL CARE OF THERADIATION ONCOLOGY PATIENTRADIATION ONCOLOGY PATIENT

CLINICAL TREATMENT MANAGEMENTCLINICAL TREATMENT MANAGEMENT

The total care of the radiation oncology The total care of the radiation oncology patient mandates patient mandates direct clinical direct clinical managementmanagement by the radiation oncologist by the radiation oncologist throughout the course of therapy.throughout the course of therapy.

It is the radiation oncologistIt is the radiation oncologist’’s s role and responsibility to role and responsibility to provide provide dailydaily supervision of supervision of treatment and hands-on, face-treatment and hands-on, face-to-face patient care.to-face patient care.

1

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 4: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Clinical Treatment ManagementClinical Treatment Management

Clinical Treatment Management starts with Clinical Treatment Management starts with the acceptance of the patient for treatment.the acceptance of the patient for treatment.

Clinical Treatment Management ends with the Clinical Treatment Management ends with the

Clinical End of Treatment report.Clinical End of Treatment report.

Clinical Treatment Management is tied Clinical Treatment Management is tied to 5 days of treatment delivery only as to 5 days of treatment delivery only as a convenient means of tracking time for a convenient means of tracking time for billing purposes.billing purposes.

2

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 5: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Clinical Treatment Management Clinical Treatment Management does not cease for nights, does not cease for nights, holidays, week ends, or any holidays, week ends, or any other time of non active other time of non active treatment deliverytreatment delivery

The physician remains The physician remains responsible for clinical responsible for clinical management as long as the management as long as the patient is under your direct patient is under your direct care.care.

2

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 6: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Historical BackgroundHistorical Background

•The original three levels of complexity descriptors for treatment management were formulated in the early 1970’s..

•The term The term ““treatment managementtreatment management”” was used to describe both the was used to describe both the supervision of treatment delivery supervision of treatment delivery and the clinical management of and the clinical management of the patient.the patient.

2

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 7: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Historical BackgroundHistorical Background

• In the Fall of 1990, AMA-CPT requested that In the Fall of 1990, AMA-CPT requested that the ACR and ASTRO CPT Committees work to the ACR and ASTRO CPT Committees work to devise a weekly treatment management devise a weekly treatment management system system that could identify physician that could identify physician procedures performed, and their procedures performed, and their complex interactions.complex interactions.

•The ACR recommended that the The ACR recommended that the AMA-CPT adopt the new code AMA-CPT adopt the new code 77427 weekly treatment 77427 weekly treatment management, effective Jan 1, management, effective Jan 1, 1991,1991, we have had this code for we have had this code for 21 years, and many physicians 21 years, and many physicians still have problems documenting still have problems documenting itit’’s use. s use.

3

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 8: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Historical BackgroundHistorical Background

•As a key part of the negotiations to achieve

77427, it was agreed that• all the items of weekly all the items of weekly

care and management care and management will be performed on a will be performed on a

regular basis and regular basis and documented by regular documented by regular under beam progress under beam progress

notesnotes

3

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 9: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

CPT Radiation Therapy CPT Radiation Therapy Treatment Management CodesTreatment Management Codes

7742777427 - - Weekly Radiation Therapy Weekly Radiation Therapy Management, 5 fractionsManagement, 5 fractions

77431 -77431 - Radiation Therapy Management; Short Radiation Therapy Management; Short course, 1 or 2 fractionscourse, 1 or 2 fractions

77432 -77432 - Radiation Therapy Management; Radiation Therapy Management;

Stereotactic, (SRS) 1 fractionStereotactic, (SRS) 1 fraction

77435 –77435 – Radiation Therapy Management; Radiation Therapy Management; SBRT, SRS, full course of therapy, up to a SBRT, SRS, full course of therapy, up to a max of 5 fractions, (2007)max of 5 fractions, (2007)

7746977469- Radiation Therapy Management; - Radiation Therapy Management; Intraoperative.Intraoperative.

4

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 10: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

CPT Radiation Therapy CPT Radiation Therapy Treatment Management CodesTreatment Management Codes

7742777427 - - Weekly Radiation Therapy Weekly Radiation Therapy Management, 5 fractionsManagement, 5 fractions

77431 -77431 - Radiation Therapy Management; Short Radiation Therapy Management; Short course, 1 or 2 fractionscourse, 1 or 2 fractions

77432 -77432 - Radiation Therapy Management; Radiation Therapy Management;

Stereotactic, (SRS) 1 fractionStereotactic, (SRS) 1 fraction

77435 –77435 – Radiation Therapy Management; Radiation Therapy Management; SBRT, SRS, full course of therapy, up to a SBRT, SRS, full course of therapy, up to a max of 5 fractions, (2007)max of 5 fractions, (2007)

7746977469- Radiation Therapy Management; - Radiation Therapy Management; Intraoperative.Intraoperative.

4

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 11: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

CPT Radiation Therapy CPT Radiation Therapy Treatment Management CodesTreatment Management Codes

7742777427 - - Weekly Radiation Therapy Weekly Radiation Therapy Management, 5 fractionsManagement, 5 fractions

77431 -77431 - Radiation Therapy Management; Short Radiation Therapy Management; Short course, 1 or 2 fractionscourse, 1 or 2 fractions

77432 -77432 - Radiation Therapy Management; Radiation Therapy Management;

Stereotactic, (SRS) 1 fractionStereotactic, (SRS) 1 fraction

77435 –77435 – Radiation Therapy Management; Radiation Therapy Management; SBRT, SRS, full course of therapy, up to a SBRT, SRS, full course of therapy, up to a max of 5 fractions, (2007)max of 5 fractions, (2007)

7746977469- Radiation Therapy Management; - Radiation Therapy Management; Intraoperative.Intraoperative.

4

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 12: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Professional billing 77427Professional billing 77427

Professional billing relates to 5 fractions Professional billing relates to 5 fractions of therapy delivered, regardless of the of therapy delivered, regardless of the number of elapsed calendar days and number of elapsed calendar days and must be billed as 77427 X 1 per 5 FX must be billed as 77427 X 1 per 5 FX block of treatments.block of treatments.

The billing date for weekly management , The billing date for weekly management , 77427, is usually the first day of each of 77427, is usually the first day of each of the 5 day blocks.the 5 day blocks.

4

10/104 Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 13: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Most of the Carriers want you to report this way

5 fractions equal one Week, bill first date of week

NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 14: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

RULE OF 5 ROUND OFFRULE OF 5 ROUND OFF 5

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 15: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Historical BackgroundHistorical Background

• It is imperative that each physician It is imperative that each physician document their direct involvement in document their direct involvement in all of the procedures related to a week all of the procedures related to a week of treatment management.of treatment management.

•It is expected that each patient It is expected that each patient will have as many regularly will have as many regularly spaced progress notes as there spaced progress notes as there are weeks of treatments.are weeks of treatments.

•The complexity and completeness of The complexity and completeness of the note must reflect the complexity the note must reflect the complexity of care for the patient.of care for the patient.

7

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 16: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

The physician will be expected to have reviewed as many of these elements as are applicable to the current course of treatment management

It is extremely important that It is extremely important that these five critical elements be these five critical elements be covered in each note.covered in each note.

I Chart and dosimetry review II Treatment setup and delivery review III Port film or electronic image review IV Under beam evaluation of the patient V Recommendation of therapy

WEEKLY UNDER BEAM PROGRESS NOTES Five Required Review Elements

7

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 17: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

•The weekly progress note does not

necessarily have to occur on the same day of each week, but for a course of therapy there should be

an equal or greater number of progress

notes than the weeks of management being

billed.

8

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 18: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Mon Tues Wed Thurs FriWeek TX TX TX TX TX TX TX TX TX TX 1 NO PROGRESS NOTE WEEK 1NO PROGRESS NOTE WEEK 1 This causes problems with This causes problems with 7742777427

Week TX TX TX TX TX TX TX TX TX TX 2 PNPN 77427

Week TX TX TX TX TX TX TX TX TX TX 3 PNPN 77427

Week TX TX TX TX TX TX TX TX TX TX 4 PNPN 77427

9

A weekly note must occur sometime during each 5 day intervalA weekly note must occur sometime during each 5 day intervalPrivileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 19: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Mon Tues Wed Thurs FriWeek TX TX TX TX TX TX TX TX TXTX 1 PN PN Having a note on week 1 is Having a note on week 1 is crucialcrucial 77427

Week TX TX TX TX TX TX TX TX TXTX 2 PNPN 77427

Week TX TX TX TX TX TX TX TX TXTX 3 PNPN 77427

Week TX TX TX TX TX TX TX TX TXTX 4 PNPN 77427

9

A weekly note must occur sometime during each 5 day intervalA weekly note must occur sometime during each 5 day interval

PN77427EOT

Having a note on the last TX date is very important

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 20: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Notice, the weekly management is being billed on the 1st date of each five-day treatment interval

The progress notes are occurring regularly on Monday regardless of the elapsed number of treatments

NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 21: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

WEEKLY PROGRESS NOTEWEEKLY PROGRESS NOTE

There is no written directive stating which day during the treatment week that the physician/patient encounter must occur.

There is no stipulation of the manner of interaction, only that it be “face to face”

9

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 22: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Which is a valid location for patient/physician encounter?Exam room

Waiting room Parking garage

Treatment console Treatment room

Hall way

9

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 23: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

ALL OF THEMALL OF THEM At each encounter this patient had the opportunity ask At each encounter this patient had the opportunity ask

question related to her course of treatment.question related to her course of treatment. At each encounter the patient acknowledges her At each encounter the patient acknowledges her

interaction with the physician.interaction with the physician. At each encounter the physician has the opportunity to At each encounter the physician has the opportunity to

evaluate the patientevaluate the patient’’s general condition.s general condition. At each encounter the physician will use his best At each encounter the physician will use his best

judgment to determine what is needed to evaluate judgment to determine what is needed to evaluate response to treatment and radiation reactionsresponse to treatment and radiation reactions

There is no written requirement related to length of time There is no written requirement related to length of time or location of the patient/physician encounteror location of the patient/physician encounter

As long as privacy concerns are metAs long as privacy concerns are met to the to the satisfaction of both the physician and satisfaction of both the physician and the patient.the patient.

10

20/104Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 24: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

WEEKLY PROGRESS NOTEWEEKLY PROGRESS NOTE

The patient /physician encounter is only The patient /physician encounter is only one of the 5 required elements of weekly one of the 5 required elements of weekly managementmanagement

The weekly progress note is a document The weekly progress note is a document covering all aspects of patient care and covering all aspects of patient care and management.management.

Each of the 5 basic elements is further Each of the 5 basic elements is further subdivided into many sub routines that subdivided into many sub routines that require individual documentationrequire individual documentation

10

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 25: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

WEEKLY PROGRESS NOTEWEEKLY PROGRESS NOTE

The production of this The production of this supporting document does not supporting document does not need to coincide with the need to coincide with the physical examination of the physical examination of the patient.patient.

It is customary done this way It is customary done this way only as a general convenience, only as a general convenience, not a requirementnot a requirement

10

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 26: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Medicare is tightening the Medicare is tightening the availability rules as part of the availability rules as part of the ““Revised Incident ToRevised Incident To”” ruling of Jan ruling of Jan 1, 2009, April 7, 2009, April 1, 1, 2009, April 7, 2009, April 1, 2010.2010.

Commercial carriers are also Commercial carriers are also beginning to pay very close beginning to pay very close attention to physician attention to physician availabilityavailability.

Availability of Physician During Treatment Management, HOPPS

11

25/104Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 27: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

•General supervisionGeneral supervision means the procedure is means the procedure is furnished under the physicianfurnished under the physician’’s overall direction s overall direction

and control, but the and control, but the physicianphysician’’s s presence is presence is not requirednot required during the performance of the during the performance of the procedure. ISODOSE PLAN, BLOCKS, DOSIMETRYprocedure. ISODOSE PLAN, BLOCKS, DOSIMETRY

•Direct supervisionDirect supervision in the office setting in the office setting

means the physician means the physician must be presentmust be present in the in the office suite and immediately available to furnish office suite and immediately available to furnish assistance and direction throughout the assistance and direction throughout the performance of the procedure. It does not mean performance of the procedure. It does not mean that that the physician must be presentthe physician must be present in the in the room when the procedure is performed. room when the procedure is performed. TREATMENT DELIVERYTREATMENT DELIVERY

•Personal supervisionPersonal supervision means a means a physician physician must be inmust be in attendanceattendance in the room during the in the room during the performance of the procedure. SIMULATION, performance of the procedure. SIMULATION, PATIENT EXAMINATIONPATIENT EXAMINATION

12

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 28: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

There shall be a full-time radiation oncologist per facility (Hospital out patient or Free standing center) immediately available, interruptible, and able to furnish assistance and direction throughout the procedure.

The attending physician or a responsible physician (Ideally THIS PHYSICIAN SHOULD

BE A RADIATION ONCOLOGIST) must be either in direct attendance or reasonably accessible during the time that radiation treatments are being delivered.

The Radiation Oncologist (CMS 2010) 12

30/104 Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 29: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

The Responsible PhysicianThe Responsible Physician

It is not in accordance It is not in accordance with the law for a Non with the law for a Non Physician practitioner Physician practitioner to provide physician to provide physician services supervision.services supervision.

13

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 30: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

INCIDENT TO SERVICESINCIDENT TO SERVICES The CMS requirements clearly state that if The CMS requirements clearly state that if

the responsible physician leaves a free the responsible physician leaves a free standing center, even to go to the hospital, standing center, even to go to the hospital, then all Medicare related services must then all Medicare related services must stop unless coverage is providesstop unless coverage is provides

The 15 minute exclusion is not mentioned, The 15 minute exclusion is not mentioned, as this was only a concession to ACR many as this was only a concession to ACR many years ago and never became part of CMS years ago and never became part of CMS policypolicy

Summary of R128BP page 13

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 31: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Coverage under –Q5Coverage under –Q5

A Medical Oncologist who has been credentialed to cover daily treatment delivery patient care,

Who is working in the same clinic,

Who is interruptible and able to respond “Right away”

-Q5 Services provided by a -Q5 Services provided by a substitute physiciansubstitute physician

14

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 32: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

If a physician is unavailable for one If a physician is unavailable for one week (5 treatments) then week (5 treatments) then the physician the physician who is covering will be the Physician of who is covering will be the Physician of RecordRecord and the Week of Management and the Week of Management

must be billed under his name. must be billed under his name.

The only exception is for locum tenens The only exception is for locum tenens coverage where the billing remains in coverage where the billing remains in

the original physicianthe original physician’’s name.s name.

14

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 33: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

THIS IS OUR BEST THIS IS OUR BEST INTERPRETATION OF INTERPRETATION OF

THE EXISTING THE EXISTING REGULATIONSREGULATIONS

Check your local carrier if Check your local carrier if in doubt about coverage, in doubt about coverage, especially in rural areas of especially in rural areas of limited medical limited medical accessibilityaccessibility

NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 34: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

INITIAL EVALUATION DOSIMETRY TREATMENT IMAGING EXAMINATIONINITIAL EVALUATION DOSIMETRY TREATMENT IMAGING EXAMINATION

UNDER BEAM PROGRESS NOTESUNDER BEAM PROGRESS NOTES

CLINICAL END OF TREATMENT SUMMARYCLINICAL END OF TREATMENT SUMMARY

FOLLOW UP NOTESFOLLOW UP NOTES

Using the cascading Using the cascading Information format, Information format, vital clinical and vital clinical and technical data may technical data may be transferred, be transferred, discarded, or added discarded, or added to each new weekly to each new weekly document as it is document as it is createdcreated

The under beam The under beam progress note is a progress note is a clinical weekly summary clinical weekly summary

documentingdocumenting the the physicianphysician’’s involvement s involvement in the weekly in the weekly management of the management of the patientpatient

NIB Narrative on page 6NIB Narrative on page 6

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 35: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Compliance and audits. These are two words that most physicians and administrators really don't like to hear.

With cascading, elements of an E/M document will copy verbatim into subsequent documents. Verbatim copying will cause cascading of old information into new encounter forms without any change.

Medicare considers that an identically copied note indicates that the physician was not actively involved in the creation of the new note. Templating has HCFA  considering severe penalties when they find large sections of notes that are 100% copies in subsequent workups.  

NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 36: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Verbatim Cut and Paste NIB

This is from HHS and DOJ

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 37: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

They Really Mean ItNIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 38: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

All physicians and users should be very much aware of this potential problem. They are well advised to carefully read any areas of their notes that are likely to change such as;

Chief Complaint, HPI, Physical Exam Review of Systems Medical decision-making Other areas may also change. Do not always use exactly the same time for every patient or type of encounter.

NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 39: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

NIB

Compliance Warning, Cascaded Information

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 40: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Original work up Six week follow-up

NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 41: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

All that is really required is a quick review of the areas of a document where you know some changes have probably occurred based upon the patient's clinical findings and treatment parameters.

Document those changes in the record. If no changes have occurred, indicate that you have reviewed that section and it is truly unchanged from the previous work up. EMRs make compliance very easy, but they also make auditing very easy.

NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 42: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

We Recommend

Any cascaded topic that has not been Any cascaded topic that has not been reviewed on a new document will reviewed on a new document will clear upon save and record.clear upon save and record.

If the topic has been opened and any If the topic has been opened and any change has been made, then the change has been made, then the changed topic and its questions and changed topic and its questions and answers will be saved.answers will be saved.

You may indicate You may indicate ““reviewed and save, reviewed and save, no change neededno change needed””..

NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 43: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Clinical exampleClinical example

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 44: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

•Verification of correctVerification of correct summation of summation of dosedose

•Verify thatVerify that time and/or monitor unitstime and/or monitor units are correctare correct..

•Stop or re-evaluation pointsStop or re-evaluation points are clearly are clearly indicatedindicated..

•The correctThe correct modalities modalities of treatment are of treatment are indicatedindicated..

•The correct beamThe correct beam energy energy is indicated.is indicated.•Proper beamProper beam modifiersmodifiers are in place.are in place.•Tumor dose is compared to theTumor dose is compared to the

tolerance dosetolerance dose ofof critical tissues.critical tissues.•Critical tissueCritical tissue dose pointsdose points are carriedare carried •The number ofThe number of treatment volumestreatment volumes is is

correctcorrect..•The numberThe number of of ports ports is correct.is correct.

# 1--Chart & Dosimetry Review

15

Document of the first day of treatment with the first under beam notePrivileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 45: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

It is understood that it is impossible for the physician to be physically present during each

and every setup, but the the physician should be physician should be readily available for readily available for corrective action should corrective action should the need arise.the need arise.

#2 Treatment Setup & Positioning Evaluation

15

Document of the first day of treatment with the first under beam note

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 46: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Radiographic films or electronic or portal imaging studies are taken at regular intervals of all of the portals being treated.

Port film review must be Port film review must be documented each week documented each week

in the under beam in the under beam progress note, if progress note, if

imaging is performed.imaging is performed.

# 3--Portal Film Review for Imaging

16

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 47: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Examination of the patient Examination of the patient consists of clinical evaluation, consists of clinical evaluation, assessment of tumor assessment of tumor response, and case response, and case management.management.

The radiation oncologist The radiation oncologist should physically examine the should physically examine the patient each week for patient each week for treatment related side effects, treatment related side effects, and tumor response.and tumor response.

# 4--UNDER BEAM EVALUATION PROGRESS

NOTE

16

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 48: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Under Beam Examination

- Every patient under Every patient under treatment, without exception, treatment, without exception, should be seen and examined should be seen and examined at least once per week at least once per week by by the physicianthe physician. .

This is a key element of the This is a key element of the weekly note. The PA can do weekly note. The PA can do much of the work, but the much of the work, but the physician must be involvedphysician must be involved

17

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 49: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

For under beam visits, these components are the same as for other E/M services.

E/M services are included in weekly management and cannot be charged separate.

17

44/104Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 50: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Many factors make up a weekly progress note, the use of multiple choice questions

with many choices of answers, makes each note unique and reduces the appearance of “macro copying”

17

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 51: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Pages 17 to 20 give a short summary of the needed elements to make up a compliant progress note.

You should follow these guide lines to format the content of your notes.

NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 52: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Every progress note should have the basic demographic information about

the patient.

21UNDER BEAM PROGRESS NOTE

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 53: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

History of Present Illness

A very short version of the patient's present illness

should be presented limited to only a few sentences

summarizing the case to-date.

21

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 54: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Current Treatment

Parameters Area(s) under treatmentEnergy/modeEvaluation of appropriateness and accuracy of all Treatment DevicesCurrent dosagePlanned dosageCritical structure dosageMicrodosimetry as doneAny corrective action as required

22

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 55: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

22A weekly review of technical factors is required, once entered, this component usually will not vary week to week, if any factors change, then the note must reflect the changes

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 56: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

23Physical Examination

ConstitutionalGeneral appearanceExamination of area under treatment must always be includedExamination of other areas as needed

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 57: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Current Status of anyTreatment Reactions

Skin reactionsGI reactionsOral cavity reactionsHematologic profilePresent weight as related to previous weight

24

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 58: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

24Tumor Response

Indicate any changes from previous work-up

Significant or subtle changes in tumor size

Expected response at current dose level

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 59: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

•Full assessment of pain•Medications and corrective actions

•Order and document medications

•Print prescriptions •Maintain a compliant list Maintain a compliant list

of all medications and of all medications and prescriptions.prescriptions.

Pain Assessment and Management

ONCOCHART

See Section 3 See Section 3 Page 8Page 8

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 60: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

e-RX Prescribe for Narcoticse-RX Prescribe for NarcoticsCovered in section 3 page 8

This is the token, a random number generator used to verify electronic narcotic prescribing.

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 61: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

New DEA controlled drug requirements

DEA regulations require a pharmacy to receive a new valid signed prescription.

DEA has further stated that a pharmacy may not provide a partially or fully pre-populated form for the prescribing practitioner.

The physician may either fax narcotic prescriptions or send electronically if pharmacy has the capability.

NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 62: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

• Patient to continuecontinue therapy• Patient placed on holdhold – state the

reason• Treatment requires modificationmodification• Patient has completedcompleted the course

of treatment

•THIS MUST BE COMPLETED BY THIS MUST BE COMPLETED BY THE PHYSICIAN EACH WEEK, THE PHYSICIAN EACH WEEK, NO OTHER PERSON CAN MAKE NO OTHER PERSON CAN MAKE THIS DECISION.THIS DECISION.

#5 Recommendation of Treatment

25

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 63: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Physician orders (CPO)Physician orders (CPO)

With electronic records, Clinical With electronic records, Clinical Physician Orders have been Physician Orders have been made much easier to deal with.made much easier to deal with.

Multiple paper forms are Multiple paper forms are eliminatedeliminated

Orders can be tailored to fit the Orders can be tailored to fit the case case

Orders can be sent electronicallyOrders can be sent electronically

25

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 64: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Physician work page has all the common procedures that require orders. This can be initiated by any authorized person in the department

A narrative is produced which can be sent electronically, faxed, or printed

25

ONCOCHART

THIS IS A MEANINGFUL USE REQUIREMENTTHIS IS A MEANINGFUL USE REQUIREMENT

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 65: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Drug Orders in Dept.

Electronic record of physician order for medication dispensed by nursing staff and signed off by physician. Compliant with JCAHO and Meaningful Use.

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 66: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

• This is a brief narrative summary of a review of any of the preceding elements that show significant change, or new developments of importance to the care of the patient.

Clinical comment regarding Current Status

ONCOCHART

26

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 67: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

26Coordination of Care•Routine progress notes should be sent to the patient’s other physicians to keep them informed of the case under treatment.

60/104Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 68: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Physician Demographics

•Every progress note should conclude with a signature of the physician of record and indication of copies to other physicians or charts.

•Electronic signature is acceptable if original signature is on file.

26

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 69: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Check-off and fill-in weekly summaries are marginally acceptable, but they must be legible and complete.

They must show that the physician has documented his/her direct involvement in the production of the weekly assessment.

27

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 70: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

NIB

This check off note just barely will suffice as a valid progress note. Demographics, vitals, dose,

and some recommendation of therapy are noted, but the rest is almost unintelligible, and far too brief, with many key elements missing,

such as a legible signature and physician name.

THIS NOTE DOES NOT MEET MEANINGFUL USE, WHICH IS NOW REQUIRED

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 71: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

This weekly under beam note is also marginal in terms of useful data, and does not meet compliance requirements.

NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 72: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

NIB

Electronically Generated Progress Notes are Preferable

NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 73: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Clinical end of treatment summary.

The clinical end of treatment summary is a non reimbursable procedure, but is absolutely necessary to indicate the termination of the course of radiation treatment.

This document should contain sufficient information to allow the requesting physician, or any other physician involved in the care of the case to fully understand the course of treatment that was just completed.

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 74: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 75: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Transition of care

If you are attesting for meaningful use a transition of care record is required, but it is also very good clinical practice.

The transition of care record, combined with an end of treatment summary allows you to transfer a great deal of meaningful information to the referring physician for their continued care of the patient.

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 76: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Transition of Care Document

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 77: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Weekly Treatment Management Weekly Treatment Management 7742777427

WhatWhat’’s it for?s it for?The physicianThe physician’’s ongoing clinical care during a course of therapy.s ongoing clinical care during a course of therapy.

Who normally documents/bills/captures this code?Who normally documents/bills/captures this code?The physician.The physician.

What Documentation is suggested for this code?What Documentation is suggested for this code?A weekly progress note (every 5 fractions) by the physician A weekly progress note (every 5 fractions) by the physician

What are the common documentation errors with this code?What are the common documentation errors with this code?Inadequate amount of information in the weekly notes.Inadequate amount of information in the weekly notes.Missing progress notes for the given number of fractions.Missing progress notes for the given number of fractions.

What are the common billing errors identified?What are the common billing errors identified?Billing this code based only on the number of fractions without Billing this code based only on the number of fractions without adequate documentation (progress notes) existing in the record.adequate documentation (progress notes) existing in the record.

BID therapy requires a progress note every 5 fractions (2 ½ BID therapy requires a progress note every 5 fractions (2 ½ calendar days)calendar days)

27

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 78: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

FIBEROPTIC ENDOSCOPYPROCEDURE CPT 31575

28

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 79: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Typical format of endoscopy report

FIBEROPTIC ENDOSCOPY

This patient is currently being treated for a T1, N0, M0, squamous cell carcinoma of the right true vocal cord. The patient has just completed his third week of radiation therapy. He is currently being treated at 180 cGy per day and is currently at 2700 cGy

Procedure: Utilizing a premedication of Pontocaine and Epinephrine applied through nasal atomizer into the right nares, the fiberoptic endoscope was inserted without difficulty. The nasal vestibule and nasal passages were carefully evaluated and found to be unchanged from the previous examination of two weeks ago. The endoscope was advanced further and the nasopharynx was clearly visualized. Both eustachian orifices were clear. A mild amount of dried secretion was noted along the posterior pharyngeal wall. None of this appears to be significant. There is a mild injection of the mucosa of the nasopharynx but no abnormalities were noted.

The endoscope was then advanced further and the hypopharynx and base of the tongue area were carefully evaluated and found to be unchanged from previous evaluations. The endoscope was then advanced into the region of the larynx. The epiglottis was noted to be symmetrical and without lesions. A moderate amount of mucositis is beginning to develop in the area of the larynx. This is most noticeable along the base of the epiglottis. Laryngeal ventricles are completely within normal limits. Pyriform sinuses are within normal limits. The false cords are beginning to show a very light edema. There is a moderate amount of mucositis throughout the perilaryngeal area.

The vocal cords move well and oppose midline. The lesion that was previously noted along the anterior aspect of the right cord is beginning to decrease in size. There is a white membrane that has formed along the area of the right anterior cord primarily in the region of the tumor. There is no membrane formation on the left cord.

The procedure was terminated without difficulty.

Impression: Expected response at three weeks of therapy with beginning resolution of tumor.

Recommendation: The patient will continue on the planed course of radiation therapy without modification.

C.R. Bogardus, Jr., M.D./nz

ONCOCHART

MAY BE REPORTED DURING AN ACTIVE COURSE OF TREATMENT

29

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 80: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

77417 Therapeutic radiology port Film(s)

Port films are taken on the treatment machine using the treatment beam to ensure that the treatment setup is as prescribed by the simulation and dosimetry.

Any changes indicated by the port films must be corrected or incorporated into the treatment plan. For coding purposes, real-time or on-line portal imaging is the same as obtaining port films.

The technical component (i.e. the costs The technical component (i.e. the costs associated with generating port films) is associated with generating port films) is reportable using code 77417reportable using code 77417..

30

70/104Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 81: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

•The review and interpretation of port films is considered as part of the weekly clinical treatment management by the physician.

•IMRT, Electron or Kilovoltage treatment may not produce port films.

•Weekly orthogonal images for IMRT setup may be billed as port films

31

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 82: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Port Films 77417Port Films 77417

WhatWhat’’s is this code for?s is this code for?Weekly Port Film or Electronic Portal Imaging.Weekly Port Film or Electronic Portal Imaging.

Who normally documents/bills/captures this code?Who normally documents/bills/captures this code?Treatment Therapist.Treatment Therapist.

When is this code normally billed?When is this code normally billed?One time per five fractions, regardless of how many images are taken.One time per five fractions, regardless of how many images are taken.

What Documentation is suggested for this code?What Documentation is suggested for this code?A notation in the chart that portal images were taken, and if any A notation in the chart that portal images were taken, and if any corrective action corrective action was needed.was needed.

What are the common documentation errors identified.What are the common documentation errors identified.The lack of physician participation in the documentation.The lack of physician participation in the documentation.

What are the common billing errors identified?What are the common billing errors identified?Billing an incorrect number of units.Billing an incorrect number of units.Billing these images professionally (they are technical only).Billing these images professionally (they are technical only).

33

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 83: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Conformal Treatment Conformal Treatment ManagementManagement•Conformal radiation therapy Conformal radiation therapy

treatment management (3-D treatment management (3-D designed) consists of clinical designed) consists of clinical

management of custom management of custom designed and blocked treatment designed and blocked treatment portals, directed to a treatment portals, directed to a treatment

volume of interest.volume of interest.

•3-D Conformal 3-D Conformal management management (not SRS, or (not SRS, or SBRT)SBRT) is to be reported is to be reported

using code 77427using code 77427

34

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 84: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

77469 Intraoperative treatment management, single session

• This code is to be utilized when This code is to be utilized when only 1 fraction makes up the only 1 fraction makes up the entire course of treatment entire course of treatment management.management.

• All management codes are All management codes are mutually exclusive per course of mutually exclusive per course of therapytherapy

34

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 85: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

77431 Short Course of Short Course of ClinicalClinical

Treatment Treatment ManagementManagement •This code is to be utilized when

only 1 or 2 fractions make up the entire course of treatment management.

•Note: This code may not be used to be reimbursed for the remaining one or two treatments at the end of a long course of therapy (ACR, 2001).

35

77/104Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 86: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Prevention of Heterotrophic Prevention of Heterotrophic Bone formationBone formation

Most commonly done following Most commonly done following major bone traumamajor bone trauma

Single treatment of 6 to 8 GySingle treatment of 6 to 8 Gy All procedures done on one day.All procedures done on one day. Consult, treatment planning, Consult, treatment planning,

simulation, blocks, dosimetry, and simulation, blocks, dosimetry, and treatmenttreatment

ICD-9 code 728.13 or V-07.8ICD-9 code 728.13 or V-07.8

36

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 87: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

HETROTROPHIC BONE PREVENTIONPOST OPERATIVE

36

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 88: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Short Course of Clinical Short Course of Clinical Treatment Management 77431Treatment Management 77431

What is this code for?What is this code for?The physicianThe physician’’s clinical care during a short course of only 1 or 2 fractions.s clinical care during a short course of only 1 or 2 fractions.

Who normally documents this code?Who normally documents this code?The physician.The physician.

When is this code normally billed?When is this code normally billed?The last day of the short course.The last day of the short course.

What Documentation is needed for this code?What Documentation is needed for this code?A progress note outlining the short course of therapy.A progress note outlining the short course of therapy.

What are the common documentation errors identified with this What are the common documentation errors identified with this code?code?No physicianNo physician’’s note being documented.s note being documented.

What are the common billing errors identified?What are the common billing errors identified?Billing this code with Brachytherapy, this is only for external beam Billing this code with Brachytherapy, this is only for external beam patients.patients.Do not report for 1 or 2 leftover fractions of at the end of a long course of Do not report for 1 or 2 leftover fractions of at the end of a long course of therapy.therapy.

39

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 89: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Chemotherapy with Radiation Treatments

41

85/104Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 90: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Chemotherapy with Radiation Treatments

• Chemotherapy, or the use of drugs to Chemotherapy, or the use of drugs to treat cancer, is a concept that has been treat cancer, is a concept that has been with us for over 40 years.with us for over 40 years.

• In the beginning, the drugs were In the beginning, the drugs were extremely toxic, and relatively ineffective.extremely toxic, and relatively ineffective.

• New drugs have been perfected which are New drugs have been perfected which are highly disease selective.highly disease selective.

• There are many drugs in use today that There are many drugs in use today that target specific cell lines of malignancy.target specific cell lines of malignancy.

• Some of these drugs are used alone, Some of these drugs are used alone, others are used in combination, and others are used in combination, and others are used in conjunction with others are used in conjunction with radiation therapy.radiation therapy.

41

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 91: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Chemotherapy with Radiation Treatments

• Chemotherapy, or the use of drugs to Chemotherapy, or the use of drugs to treat cancer, is a concept that has been treat cancer, is a concept that has been with us for over 40 years.with us for over 40 years.

• In the beginning, the drugs were In the beginning, the drugs were extremely toxic, and relatively ineffective.extremely toxic, and relatively ineffective.

• New drugs have been perfected which are New drugs have been perfected which are highly disease selective.highly disease selective.

• There are many drugs in use today that There are many drugs in use today that target specific cell lines of malignancy.target specific cell lines of malignancy.

• Some of these drugs are used alone, Some of these drugs are used alone, others are used in combination, and others are used in combination, and others are used in conjunction with others are used in conjunction with radiation therapy.radiation therapy.

41

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 92: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

•Almost all of the Almost all of the chemotherapeutic agents are chemotherapeutic agents are highly toxic and create various highly toxic and create various medical problems for the patient medical problems for the patient in addition to their beneficial in addition to their beneficial effects against the malignancy.effects against the malignancy.

•The beneficial effects of these The beneficial effects of these drugs usually will out weigh the drugs usually will out weigh the toxic side effects, and for this toxic side effects, and for this reason chemotherapy plays a reason chemotherapy plays a very important role in the overall very important role in the overall management scheme of patients management scheme of patients with malignancy.with malignancy.

41

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 93: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

•When chemotherapy is used, the acute When chemotherapy is used, the acute and long-term effects, must be taken and long-term effects, must be taken into account by the radiation into account by the radiation oncologist.oncologist.

•Patients receiving chemotherapy tend Patients receiving chemotherapy tend to be sicker and require closer and to be sicker and require closer and more careful attentionmore careful attention

•The treatment planning and The treatment planning and treatment management of the treatment management of the course of therapy will always be course of therapy will always be complex. This will be true even in complex. This will be true even in what otherwise, would have been what otherwise, would have been a simple case. a simple case.

41

88/104Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 94: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

7747077470 Special treatment procedure Special treatment procedure (e.g. total body irradiation, (e.g. total body irradiation, hemibody hemibody irradiation, per oral endo-cavitary or irradiation, per oral endo-cavitary or intra-operative cone irradiation)intra-operative cone irradiation)

This code covers the additional This code covers the additional physician effort and work required for the physician effort and work required for the special procedures of, total body special procedures of, total body irradiation, hemibody irradiation, irradiation, hemibody irradiation, intracavitary cone use, Brachytherapy, intracavitary cone use, Brachytherapy, hyperthermia, hyperthermia, concurrent chemotherapyconcurrent chemotherapy, , radiation response modifiers, stereotactic radiation response modifiers, stereotactic radiosurgery (single fraction or radiosurgery (single fraction or fractionated), fractionated), intra-operative radiation intra-operative radiation therapy, therapy, 3-D CRT, IMRT3-D CRT, IMRT (removed 2012(removed 2012)), , heavy particles (e.g. protons/neutrons),heavy particles (e.g. protons/neutrons), and any and any other special time-consuming and other special time-consuming and complex treatment procedure. complex treatment procedure.

))

Special Treatment Procedure Special Treatment Procedure 7747077470

42

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 95: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

The code 77470, is designated The code 77470, is designated to cover the additional time and to cover the additional time and effort required effort required of the physician of the physician and the hospital technical staffand the hospital technical staff while performing and/or while performing and/or managing special treatment managing special treatment situationssituations.

This code may be reported only This code may be reported only one time per course of therapy.one time per course of therapy.

42

77470 IS A GLOBAL BILLLING CODE77470 IS A GLOBAL BILLLING CODE

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 96: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

SPECIAL TREATMENT PROCEDURE WORKPAGESPECIAL TREATMENT PROCEDURE WORKPAGE

Note the Note the many many

different different indications indications

for reporting for reporting the special the special treatment treatment procedure, procedure,

7747077470

43

ONCOCHARTPrivileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 97: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Can anything better exemplify special treatment procedure than pediatric anesthesia?

NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 98: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

A narrative note is absolutely necessary as the backup documentation for 77470. Simply including a line in a weekly progress note is not sufficient documentation to justify the billing of this code. The reasons are all here, just make certain that they are verbalized.

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 99: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Special Procedure NoteThis patient has just completed three months of multi-drug chemotherapy by Dr.

Ishmael. We have been watching the patient over the last few weeks as the counts have slowly risen to a respectable level. The patient now has 4500 WBC's and 217,000 platelets. Patient still has marked alopecia from the chemotherapy.

Considerable time was spent this morning with the patient and the patient's family explaining the possibility of continued, severe, interactions between the radiation and the just completed course of chemotherapy. It is anticipated that the patient will be experiencing a marked increase in skin reactions because of the course of Adriamycin. The treatment portals will be close to the heart, but every effort will be made to avoid treating any of the myocardium. The patient and the patient's family do understand the possibility of severe reactions and difficulties that will probably be experienced during the forthcoming course of radiation treatments.

The course of radiation therapy over the next six weeks will be carefully coordinated with Dr. Ishmael. Dr. Ishmael will be available to handle any medical problems that may arise during this period of time. We will be observing the patient on a daily basis during the first part of the course of treatment to make certain that reactions are not excessive.

The patient and the patient's family fully understand that the treatments are absolutely necessary but that the patient will experience considerable discomfort and other interrelated problems during the next few weeks.

Carl R. Bogardus, Jr., M.D.ONCOCHART

43

92/104 Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 100: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Multiple reasons for 77470

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 101: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Special Treatment ProceduresSpecial Treatment Procedures7747077470WhatWhat’’s it for?s it for?

The additional effort involved in caring for patients under highly complex The additional effort involved in caring for patients under highly complex circumstances.circumstances.

Who normally documents this code?Who normally documents this code?Varies widely, but usually the physician. Varies widely, but usually the physician.

When is this code normally billed?When is this code normally billed?Upfront at the same time as the physicianUpfront at the same time as the physician’’s clinical treatment planning. s clinical treatment planning.

What Documentation is suggested for this code?What Documentation is suggested for this code?A physician narrative explaining medical necessity.A physician narrative explaining medical necessity.

What is the common documentation error identified with this code?What is the common documentation error identified with this code?Not documenting the code with a separate written document.Not documenting the code with a separate written document.

What are the common billing errors identified?What are the common billing errors identified?Missing the code due to inadequate documentation of the procedure.Missing the code due to inadequate documentation of the procedure.There is no There is no ““physicalphysical”” event to trigger billing, it must be recognized by event to trigger billing, it must be recognized by circumstances.circumstances.

44

SP89/104Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 102: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

BILLING INPATIENT CARE BILLING INPATIENT CARE FROM A FREESTANDING FROM A FREESTANDING

CENTER OR HOSPITAL BASED CENTER OR HOSPITAL BASED PROGRAMPROGRAM By law, Medicare stipulates By law, Medicare stipulates

that the technical component that the technical component of inpatient radiation therapy of inpatient radiation therapy must be included as part of must be included as part of the DRG of the admission the DRG of the admission

45

94/104Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 103: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

RADIATION THERAPY DRGRADIATION THERAPY DRG There are 523 DRG CodesThere are 523 DRG Codes Code 409 is the only DRG with radiation Code 409 is the only DRG with radiation

therapytherapy 409 is defined as concomitant 409 is defined as concomitant

chemotherapy and radiation therapy chemotherapy and radiation therapy during the admissionduring the admission

DRG codes do not include additional DRG codes do not include additional reimbursement for radiation therapyreimbursement for radiation therapy

This is why you are discouraged from This is why you are discouraged from starting therapy while a hospital inpatientstarting therapy while a hospital inpatient

45

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 104: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

If the patient is a Medicare If the patient is a Medicare recipient and becomes recipient and becomes hospitalized as an inpatient, but hospitalized as an inpatient, but being transported to a being transported to a freestanding center each day for freestanding center each day for treatment, then the patient must treatment, then the patient must be billed as an inpatient, not as be billed as an inpatient, not as an outpatientan outpatient. .

Most freestanding centers have Most freestanding centers have contracts with hospitals to cover these contracts with hospitals to cover these situations. situations. Hospital owned departments make Hospital owned departments make these corrections internally.these corrections internally.

46

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 105: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Skilled Nursing FacilityPatients admitted to a skilled Patients admitted to a skilled

nursing facility (SNF) nursing facility (SNF) under the under the part A benefit or a Medicare part A part A benefit or a Medicare part A stay are considered to be hospital stay are considered to be hospital

inpatients,inpatients, and as such are and as such are covered under a specific DRG of covered under a specific DRG of

admission. admission. Treatment of these patients Treatment of these patients

requires the technical component requires the technical component of treatment to be billed to the of treatment to be billed to the

SNF, not Part B. SNF, not Part B. This may not apply to private This may not apply to private

insuranceinsurance

46

SP98/104Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 106: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

HYPERTHERMIAHYPERTHERMIA

Covered by codes 77600 to Covered by codes 77600 to 7762077620

Payment value of coverage Payment value of coverage of treatment by negotiation of treatment by negotiation with local insurance carrierswith local insurance carriers

46

77600 – 77620 ARE GLOBAL BILLING CODES77600 – 77620 ARE GLOBAL BILLING CODES99/104 Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 107: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

BSD Phased Array hyperthermia unit

48

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 108: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

HYPERTHERMIA ISOTHERMIC PLAN

NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 109: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

AVAILABLE CODESAVAILABLE CODES

Only the Hyperthermia delivery codes are Only the Hyperthermia delivery codes are specific to Hyperthermia.specific to Hyperthermia.

77600 Superficial up to 4 cm depth77600 Superficial up to 4 cm depth 77605 Deep over 4 cm in depth77605 Deep over 4 cm in depth 77610 Probes (interstitial) 5 or less probes77610 Probes (interstitial) 5 or less probes 77615 Probes (interstitial) 6 or more 77615 Probes (interstitial) 6 or more

probesprobes 77620 Probes ( intracavitary) any number77620 Probes ( intracavitary) any number New codes were planned for 2009New codes were planned for 2009

49

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 110: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

CODES THAT CAN BE USEDCODES THAT CAN BE USED 77263 Complex treatment planning77263 Complex treatment planning 77470 Special treatment procedure77470 Special treatment procedure 77290 Initial set up simulation77290 Initial set up simulation 77280 Subsequent simulations same area77280 Subsequent simulations same area 77305 Isothermic plan, superficial77305 Isothermic plan, superficial 77310 Isothermic plan deep one port77310 Isothermic plan deep one port 77315 Isothermic plan deep, multiple ports77315 Isothermic plan deep, multiple ports 77295 Isothermic plan, 3-D planning77295 Isothermic plan, 3-D planning 77326 Isothermic plan interstitial up to 4 probes77326 Isothermic plan interstitial up to 4 probes 77327 Isothermic plan interstitial, 5-10 probes77327 Isothermic plan interstitial, 5-10 probes 77328 Isothermic plan interstitial, over 10 probes77328 Isothermic plan interstitial, over 10 probes 77328 Isothermic plan intracavitary77328 Isothermic plan intracavitary 77300 Basic Dosimetry for heating time 77300 Basic Dosimetry for heating time

calculationscalculations 77300 Calculation of areas of maximal or minimal 77300 Calculation of areas of maximal or minimal

heatingheating

49

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 111: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

PRINCIPLES OF BILLING, CODING

AND COMPLIANCE IN RADIATION ONCOLOGY

BMSi 2014

END 11

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 112: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

END OF SECTION 11

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 113: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 114: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

MEDICARE (CMS), 2010, REQUIRESMEDICARE (CMS), 2010, REQUIRES

There shall be a full-time There shall be a full-time physician, preferably a radiation physician, preferably a radiation oncologist, per facility, physically oncologist, per facility, physically available on a daily basis for direct available on a daily basis for direct supervision of daily treatment, and supervision of daily treatment, and management of any patient management of any patient related treatment problems.related treatment problems.

The 5 elements of weekly The 5 elements of weekly management must be documented management must be documented by this physician for each week of by this physician for each week of treatment.treatment.

7

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 115: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Trail Blazer opinion June 2010Trail Blazer opinion June 2010

For billing radiation treatment For billing radiation treatment management, 77427, Medicare management, 77427, Medicare expects the radiation oncologist to expects the radiation oncologist to bill the weekly management code bill the weekly management code for the management related to for the management related to five consecutive treatment five consecutive treatment delivery sessions and to have seen delivery sessions and to have seen the patient at least once during the patient at least once during that time period. that time period. The actual The actual visit could occur anytime visit could occur anytime during that time period.during that time period.

11

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 116: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

R128BP page 13

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 117: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

23

PainAmbulationSocial interactionsMemoryPsycho-social adjustmentNutritional status should always be mentioned as related to present weightPhysician/patient self assessment of Q of L

Assessment of Quality of Life

51/104

Generally done by the nursing staff but must be reviewed by the physician

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 118: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

• Review of current portal films or images• Comparison with previous portal films or images• Comparison with simulation films or images• Comparison with appropriate diagnostic imaging• Corrective action if necessary• Review of corrected portal films or images•Indicate if films not required (electrons, superficial)

Review of Portal Images

ONCOCHART

31

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 119: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Total Body or Hemi body Radiation Therapy

Total or hemi body therapy is an Total or hemi body therapy is an extremely complex procedure extremely complex procedure requiring a great deal of physician requiring a great deal of physician input, often requiring special testing, input, often requiring special testing, consultations, and physics consultations, and physics evaluations.evaluations.

When only one or two treatments are When only one or two treatments are given for the entire course of therapy, given for the entire course of therapy, you should bill short course of you should bill short course of treatment management 77431.treatment management 77431.

37

80/104Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 120: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

992XX High Complexity Evaluation77263 Therapeutic Radiology Treatment Planning; Complex77290 Therapeutic Radiology Simulation; Complex

Simulation may be repeated on different days during the initial setup procedures.77300 Basic Radiation Dosimetry Calculation

This may be calculated on many occasions. This may be reported as many times as performed and Documented.77321 Special Teletherapy Port Plan (Electrons, if used)77336 Continuing Medical Physics Support, 1 charged for 1 to 5 fractions.77370 Special Medical Radiation Physics Consultation

As Requested By the radiation oncologist.Usually only 1 of these would be required

for a total body course of treatment.

Valid charges for total body radiation therapy 38

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 121: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

77331 Special Dosimetry (TLD or Diode Microdosimetry)

This may be billed as often as requested to cover all measured dose points.77334 Special Shields Special shields for the lungs may be constructed.77427 Weekly Megavoltage Treatment Management –22,

If over 2 treatments given, Modifier –22 is used to increase the billed value.77431 Short Course Clinical Treatment Management -22

Modifier –22 may be used to increase the value of this code.77417 Port Films, 1 charge is allowed per week (5 fractions) of treatment.77470 Special Treatment Procedure -22 Modifier –22 may be used for a one-time charge for the special treatment procedure.

38

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 122: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Review of Laboratory Data Review of Laboratory Data (page 18-19)(page 18-19)

Laboratory tests, should be discussed Laboratory tests, should be discussed andand summarizedsummarized Comparison to previous laboratory Comparison to previous laboratory workwork Indicate corrective actions if Indicate corrective actions if necessarynecessary Ordering of any new testing as Ordering of any new testing as requiredrequired

Review of Diagnostic Imaging Review of Diagnostic Imaging Studies ( page 19)Studies ( page 19)

Compare with previous imaging Compare with previous imaging studiesstudiesCompare with current portal films Compare with current portal films if indicatedif indicatedOrdering of any new testing or Ordering of any new testing or imaging as requiredimaging as requiredPrivileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 123: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Look at errors on note

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 124: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Rework incident toRework incident to

Decrease number of slidesDecrease number of slides Clean up wordingClean up wording

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 125: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Month End CrossingMonth End CrossingOn March 2009 the National Government Services,  a CMS contracting agent "clarified" the proper reporting of 77427. This is reported  in the Medicare Claims processing manual (100-04), Chapter 13, Section.1.In the event that five fractions occur in two different calendar months or years, the billing "from and to" dates should reflect the month in which the most fractions were performed.

NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 126: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

“Clarified” method of Billing

3 Fractions make up this week

Bill first date of “clarified” week

Week MgmtOrphaned

dateOrphaned date

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 127: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

This makes the billing more difficult

Orphaned dateOrphaned dateWeek Mgmt

We then return to a conventional 5 day week but what do we do with the 2

orphaned dates?

NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 128: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

Even More Difficult with 2 days in each Crossing Segment

Which set has the week of management billed, and if only 2 fractions make up the end of a course, you cannot bill a week of

management, so do we loose the last week of 77427 management billing?????

NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 129: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

INCIDENT TO SERVICESINCIDENT TO SERVICES

The Physician direct supervision The Physician direct supervision requirements are required if the requirements are required if the services are performed within a services are performed within a hospital, the physician must be hospital, the physician must be within the hospital,within the hospital, but not but not necessarily in the radiation therapy necessarily in the radiation therapy department,department, this has been clearly this has been clearly stated by CMS in the ruling of April 7, stated by CMS in the ruling of April 7, 20002000

Summary of R128BP page 13

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 130: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

ASTRO Comments, 04-30-12NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 131: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

This illogical scheme of reporting will This illogical scheme of reporting will make billing and auditing very difficult make billing and auditing very difficult for no rational  purpose. I recall this for no rational  purpose. I recall this same proposal about the year 1991 as same proposal about the year 1991 as the code 77427 was brought into use. the code 77427 was brought into use. This was soon changed to ignore the This was soon changed to ignore the monthly crossing recommendation as monthly crossing recommendation as being far too difficult to bill and audit. being far too difficult to bill and audit.

If your carrier is forcing you to use this If your carrier is forcing you to use this method, you should protestmethod, you should protest

NIB

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 132: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

INCIDENT TO SERVICESINCIDENT TO SERVICES If the hospital owned radiation therapyIf the hospital owned radiation therapy

department isdepartment is not physically locatednot physically located within, or connected to, the hospital, i.e., within, or connected to, the hospital, i.e., a free standing center thena free standing center then the the physician physician must be must be ““InterruptibleInterruptible”” and able to and able to intervene intervene ““right awayright away”” when Medicare when Medicare patients are being treatedpatients are being treated.. Free standing, non hospital owned Free standing, non hospital owned

centers are subject to this centers are subject to this requirementrequirement

Summary of R128BP page 13

Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege

Page 133: This will be a session this morning covering section 10 Susan Vannoni Dr Bogardus Scott Simmons THIS SCHEDULE MAY BE MODIFIED DEPENDING UPON SPEAKER AVAILABILITY

PORTAL-VISION IMAGES (ARIA-VARIAN)

BLENDED IMAGES

DRR

PORTAL IMAGE

31

72/104 Privileged and Confidential Work Product – Subject to the Attorney – Client Privilege